SCHEMBL26667482

SCHEMBL26667482

O=C(O)NCCCC(C(=O)NCC(=O)c1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
HPGD P15428 2/20 0.44
DUSP3 P51452 1/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44
HSD17B10 Q99714 2/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 2/20 0.43
TP53 P04637 1/20 0.43
GLA P06280 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALOX12 P18054 1/20 0.43
NFKB1 P19838 1/20 0.43
APEX1 P27695 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD11B1 P28845 1/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26667471 1.00 ALDH1A1 (0.44) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL26667464 0.86 AGTR1 (0.47) ALDH1A1HPGDPOLBMEN1KMT2A
SCHEMBL26667470 0.86 AGTR1 (0.47) ALDH1A1HPGDPOLBMEN1KMT2A
SCHEMBL26902846 0.85 FOLH1 (0.48) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL30613477 0.85 FOLH1 (0.48) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL394112 0.81 MEN1 (0.62) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL394111 0.81 MEN1 (0.62) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL26667477 0.77 ALDH1A1 (0.42) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL26667481 0.77 ALDH1A1 (0.42) ALDH1A1HPGDDUSP3PTPN5PTPN11
SCHEMBL7061501 0.76 ALDH1A1 (0.50) ALDH1A1HPGDDUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381146-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF HELIOS HUAMING BIOPHARMA CO., LTD. (CN) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381146-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF SSB, BTK, PADI6 ALDH1A1 1123/4885HPGD 2296/4885DUSP3 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.